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June Supplement 201186S Abstracts1.05 /0.11mm and 1.24 /0.09mm in the 3-min-
ute time group (p NS between groups). Intimal hyperplasia
was modest in all rats, with no significant differences in
intimal wall areas. The intimal and medial wall area as a
percentage of overall vessel area was 35.0 /5.2% in the
30-second group and 36.8 /6.6% in the 3-minute
group (p NS).
Conclusions: Prolonged balloon inflation time failed
to produce significant changes in intimal disruption after
24 hours. At 30 days, there was no difference in the amount
of intimal hyperplasia, medial wall thickening, or lumen
diameter compared to standard inflation times. These re-
sults do not support changing current balloon angioplasty
practices.
Author Disclosures: D. Boone: Nothing to disclose; G.
Jour: Nothing to disclose; J. C. Lantis: Nothing to dis-
close; G. S. Schwartz: Nothing to disclose.
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PS218.
Inhibition of CXCL4-CCL5 Chemokine Interaction
Ameliorates the Development of Abdominal Aortic
Aneurysm in Mice
Yasunori Iida1, Baohui Xu1, Joshua Schultz2, Court R.
Turner2, Ronald L. Dalman1. 1Vascular Surgery, Stanford
University School of Medicine, Stanford, CA; 2Carolus
Therapeutics, Inc., La Jolla, CA
Objectives: Abdominal aortic aneurysm (AAA) is a
macrophages-driven vascular disease. Given the importance
of CXCL4-CCL5 chemokine interaction in macrophage/
monocytes migration into inflamed arteries, we evaluated
the effect of a novel synthetic peptide inhibitor to CXCL4-
CCL5 interaction on AAA progression in the porcine pan-
creatic elastase (PPE)-induced AAA mouse model.
Methods: AAA was created in 10-wk-old male
C57BL/6 mice by PPE infusion into infrarenal aorta.
These mice were injected i.v. with the synthetic peptide
inhibitor to CXCL4-CCL5 interaction (CT-2009ca, 10
(n5) or 20 (n7) mg/kg/day or the vehicle (n8)
(Carolus Therapeutics, Inc) for 3 days before PPE infusion
and 13 days thereafter. The AAA was imaged by ultra-
sonography and defined as a 50% increase in the aortic
diameter. The aortae were harvested 14 days after PPE
infusion and subjected to histopathology.
Results: AAA developed in all mice treated with the
vehicle within 7 days. In contrast, AAA developed in 3mice
and 1 mouse treated with the CT-2009ca at the dose of 10
and 20 mg /kg/day, respectively, within 14 days. The
CT-2009ca treatment dose-dependently inhibited the
PPE-induced increase in aorta diameter. Moreover, the
elastic Masson staining and the anti-smooth muscle cell
alpha actin antibody immunostaining revealed that medial
elastin fibers and smooth muscle cell layers were well pre-
served in the CT-2009ca-treated mice as compared to the
vehicle-treated mice. As expected, the CT-2009ca treat- sent significantly reduced the numbers of macrophages,
D4 T cells and neutrophils and newly formed blood
essels in the media and adventitia by immunostaining with
he mAbs against leukocyte subsets and endothelial cells.
Conclusions: In the mouse PPE model of AAA, inhi-
ition of CXCL4-CCL5 interaction by CT-2009ca sup-
ressed AAA development by reducing angiogenesis and
imitingmedial and adventitial infiltration of certain subsets
f leukocytes. Thus, CT-2009ca may be a potential thera-
eutic candidate for treating human AAA disease.
uthor Disclosures: R. L. Dalman: Nothing to disclose;
. Iida: Nothing to disclose; J. Schultz: Nothing to dis-
lose; C. R. Turner: Nothing to disclose; B. Xu: Nothing
o disclose.
S220.
hermo-Mechanical Resistance of a Nanocomposite
olymer Exposed to Simulated in Vivo Hydrodynamic
atigue for Ten Years in Development of a Sutureless
ndovascular Stent Graft
ital Y. Desai1, Raheleh Bakhshi2, Arnold Darbyshire2,
ax Ahmed2, James Eaton-Evans3, Xiang Zhou3, Zhong
ou3, AlexanderM. Seifalian2, GeorgeHamilton1. 1Vascu-
ar Surgery, Royal Free Hampstead NHS Trust, London,
nited Kingdom; 2Division of Surgery and Interventional
cience, University College London, London, United
ingdom; 3Department of Engineering Science, Univer-
ity of Oxford, Oxford, United Kingdom
Objectives: To physiologically test thermo-mechanical
esistance of a nanocomposite polymer based on polyhedral
ligomeric silsesquioxane (POSS) and poly (carbonate-
rea) urethane (PCU) to assess its feasibility as graft mate-
ial for a sutureless aortic stent-graft by exposing it to
imulated in vivo hydrodynamic fatigue according to FDA
uidelines.
Methods: Aortic stent-grafts (n4) were tested in 37
egree Celsius distilled water using in vitro accelerated
ircumferential pulsatile model. After analysis for 400-mil-
ion cycles equivalent to 10-years in human body, the
echanical and elastic properties were determined by Fou-
ier transform infrared spectroscopy (FTIR), radial stress-
train studies, and linear elasticity tests. Dynamic scanning
alorimetry (DSC) and Thermo-mechanical analysis
TMA) were used to assess thermal resistance. Comparison
as made with zero-cycled control.
Results: All stent-grafts (n4; diameter 250.1 mm;
ength 25.30.5 cm) successfully completed accelerated
ulsatile fatigue testing at 37°C and pulse pressure 9414
m Hg over 12 months. FTIR showed increased intensity
f -NHCO- bonds (62% transmittance in tested specimen
ompared to 47% in control) but there was no difference in
ntensity of other major bonds and no significant sign of
egradation. Tensile strain of fatigue-tested polymer com-
ared favourably with zero-cycled control at 50% to 500%
tress (P0.69). When stretched up to 500% original
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Volume 53, Number 17S Abstracts 87Slength, there was no difference in linear elasticity (deforma-
tion 13.3% in tested specimen compared to 12.3% in con-
trol; P0.74). DSC and TMA showed decrease in glass
transition temperature up to 4°C but thermo-tropic tran-
sition was comparable to control.
Conclusions: Simulated physiological in vivo hydrody-
namic fatigue has no significant degradative effect on an
innovative stent-graft from POSS-PCU nanocomposite
polymer. Sutureless technology incorporating nitinol stents
proved to be robust with no separation over accelerated
10-year cycle.
Author Disclosures: M. Ahmed: Nothing to disclose; R.
Bakhshi: Nothing to disclose; A. Darbyshire: Nothing to
disclose; M. Y. Desai: Nothing to disclose; J. Eaton-
Evans: Nothing to disclose; G. Hamilton: Nothing to
disclose; A. M. Seifalian: Nothing to disclose; Z. You:
Nothing to disclose; X. Zhou: Nothing to disclose.
PS222.
Percutaneous Peri-Adventitial Guanethidine Delivery
Induces Renal Artery Sympathectomy: Preclinical Ex-
perience and Implication for Refractory Hypertension
Christopher Owens1, Warren J. Gasper1, Kirk Seward3,
Sanjay Misra4, Stewart B. Jacobson2, Russell M. Jones2.
1University of California San Francisco, San Francisco, CA;
2CVPath, Gaithersburg, MD; 3Mercator MedSystems, San
Leandro, CA; 4Mayo Clinic, Rochester, MN
Objectives: Renal efferent sympathetic nerve overac-
tivity is contributory to the hypertensive state. Guanethi-
dine is known to induce an autonomic denervation through
an immune mediated pathway.We hypothesized that
guanethidine could be safely delivered into the renal peri-
vascular space to produceautonomic denervation and re-
duction in renal norepinephrine (NE) content.
Methods: A micro-infusion catheter (Mercator Med-
Systems) was introduced via the femoral artery into the
renal arteries of (N11) female swin.Two to three ml of
guanethidine (20-30 mg) or vehicle, each with 20% dilu-
tion of contrast, was infused into the adventitial space
under fluoroscopic guidance. The primary efficacy end-
point in this study was kidney NE tissue content measured
by high-performance liquid chromatography.Secondary
outcomes included histological evidence of renal artery
denervation to corroborate efficacy and renal artery injury
and neural inflammation scores.
Results: There were 18 treated renal arteries and 4
vehicle controls in this study.There was 100% procedural
success in the delivery of guanethidine or vehicle to the
renal artery adventitial space.The mean renal artery injury
scores were not different between treated and control pigs
(PNS), and in all cases the endothelial integrity was
maintained.However,in all guanethidine-treated cases
there was histological evidence of peri-neural inflammation
and nerve destruction whereas the nerves appeared normal
in all control animals.There was an overall decrease in renal mortex NE content in a dose dependent fashion, control
4534 ng/g tissue, 20 mg dose 16118 ng/g tissue and
0 mg dose 13316 ng/g tissue, P.038 (Figure).
Conclusions: These data support the hypothesis that
uanethidine can be delivered safely and efficiently into the
enal peri-adventitial space through a novel minimally in-
asive technique.Further, renal NE content is significantly
educed suggesting that this could be a viable procedure in
he treatment of refractory sympathetic-driven hyperten-
ion.
uthor Disclosures: W. J. Gasper: Nothing to disclose;
. B. Jacobson: Nothing to disclose; R. M. Jones: Noth-
ng to disclose; S. Misra: Nothing to disclose; C. Owens:
othing to disclose; K. Seward: Mercator MedSystems,
wnership or PartnershipR43HL102998, Research
rants.
S224.
orcine Mesenchymal Stem Cell Labeling with MRI
ontrast Agent Ferex
ehrnoosh Shahrivar1, Daniel K. Han1, Karen Briley-
aebo2, Andrew Tye1, Michael L. Marin1, Peter L. Faries1.
Division of Vascular Surgery, Department of Surgery,
ount Sinai School of Medicine, New York, NY; 2Depart-
ent of Radiology, Mount Sinai School of Medicine, New
ork, NY
Objectives: Mesenchymal stem cell (MSC) transplan-
ation is currently being investigated in porcine abdominal
ortic aneurysm (AAA) models for its potential as regener-
tive treatment. Reliable methods of labeling and tracking
SCs are necessary to evaluate their effects. This study
ims to evaluate in vitro performance of Ferex, a superpara-
agnectic iron oxide that can be tracked by magnetic
